Li R - Search Results

1

Treatment of hematologic malignancies with alternate hemibody irradiation combined with high-dose chemotherapy: a single-center experience.

Wei J, Wang M, Zou D, Yang D, Li R, Ning J, Feng S, Han M. Wei J, et al. Among authors: li r. Int J Hematol. 2004 Dec;80(5):435-40. doi: 10.1532/ijh97.a10322. Int J Hematol. 2004. PMID: 15646656

2

[Preliminary study on alternative half body irradiation in the treatment of hematological malignancies].

Wei JL, Wang M, Zou DH, Yang DL, Li R, Ning J, Feng SZ, Han MZ. Wei JL, et al. Among authors: li r. Zhonghua Xue Ye Xue Za Zhi. 2004 Jun;25(6):355-8. Zhonghua Xue Ye Xue Za Zhi. 2004. PMID: 15308016 Chinese.

3

[The outcome analysis of different treatment regimens in 206 patients with multiple myeloma].

Mai YJ, Li R, Zou DH, Wang YF, Zhao YZ, Yang RC, Wang JX, Xiao ZJ, Han MZ, Qian LS, Qiu LG. Mai YJ, et al. Among authors: li r. Zhonghua Xue Ye Xue Za Zhi. 2005 Apr;26(4):193-6. Zhonghua Xue Ye Xue Za Zhi. 2005. PMID: 15949257 Chinese.

4

[Analysis of long-term treatment outcome and related factors in 95 chronic myeloid leukemia patients treated with imatinib].

Wang GR, Zhao YZ, Qian LS, Zou DH, Li R, Mi YC, Wang XX, Qiu LG. Wang GR, et al. Among authors: li r. Zhonghua Xue Ye Xue Za Zhi. 2008 Jan;29(1):18-22. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18512310 Chinese.

5

The prognostic significance of leukemic cells clearance kinetics evaluation during the initial course of induction therapy with HAD (homoharringtonine, cytosine arabinoside, daunorubicin) in patients with de novo acute myeloid leukemia.

Xiao Z, Xue H, Li R, Zhang L, Yu M, Hao Y. Xiao Z, et al. Among authors: li r. Am J Hematol. 2008 Mar;83(3):203-5. doi: 10.1002/ajh.21068. Am J Hematol. 2008. PMID: 17874451 Free article.

6

[Preliminary observation of the combination of arsenic trioxide and all-trans retinoic acid for the treatment of acute promyelocytic leukemia].

Zhao YZ, Li HQ, Li DP, Li R, Qi JY, Wan CC, Zhou CL, Wang ZQ, Qian LS. Zhao YZ, et al. Among authors: li dp, li r, li hq. Zhonghua Xue Ye Xue Za Zhi. 2003 Jan;24(1):32-4. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 12679008 Chinese.

7

[Long-term therapeutic outcome of patients with acute promyelocytic leukemia].

Zhang L, Li R, Li DP, Liu YZ, Xu SC, Hao YS, Xiao ZJ. Zhang L, et al. Among authors: li r, li dp. Zhonghua Xue Ye Xue Za Zhi. 2007 Jan;28(1):15-8. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 17649719 Chinese.

8

A Novel Therapeutic siRNA Nanoparticle Designed for Dual-Targeting CD44 and Gli1 of Gastric Cancer Stem Cells.

Yao H, Sun L, Li J, Zhou X, Li R, Shao R, Zhang Y, Li L. Yao H, et al. Among authors: li j, li l, li r. Int J Nanomedicine. 2020 Sep 23;15:7013-7034. doi: 10.2147/IJN.S260163. eCollection 2020. Int J Nanomedicine. 2020. PMID: 33061365 Free PMC article.

9

Dual actions of albumin packaging and tumor targeting enhance the antitumor efficacy and reduce the cardiotoxicity of doxorubicin in vivo.

Zheng K, Li R, Zhou X, Hu P, Zhang Y, Huang Y, Chen Z, Huang M. Zheng K, et al. Among authors: li r. Int J Nanomedicine. 2015 Aug 24;10:5327-42. doi: 10.2147/IJN.S84478. eCollection 2015. Int J Nanomedicine. 2015. PMID: 26346331 Free PMC article.

10

Deguelin blocks cells survival signal pathways and induces apoptosis of HL-60 cells in vitro.

Chen Y, Wu Q, Cui GH, Chen YQ, Li R. Chen Y, et al. Among authors: li r. Int J Hematol. 2009 Jun;89(5):618-23. doi: 10.1007/s12185-009-0307-4. Epub 2009 May 20. Int J Hematol. 2009. PMID: 19455392

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35,499 results

Search Page

Filters